arrow
A

Anna Gaulton

european molecular biology laboratory (embl)
H指数:34
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods
2023-11-02162
OAAI
Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics

利用人类遗传学验证冠心病预防的脂质相关治疗靶点

2021-10-2113
OAAI
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19

可行的药物全基因组孟德尔随机化确定了重新利用新型冠状病毒肺炎的机会

2021-04-09123
OAAI
ChEMBL: towards direct deposition of bioassay data

ChEMBL: 走向生物测定数据的直接沉积

2018-11-061.3K
OAAI
Unexplored therapeutic opportunities in the human genome (vol 17, pg 317, 2018)

人类基因组中未开发的治疗机会 (第17卷,317页,2018页)

2018-03-2323
OAAI
Unexplored therapeutic opportunities in the human genome

人类基因组中未开发的治疗机会

2018-03-23278
OAAI
Pharos: Collating protein information to shed light on the druggable genome

Pharos: 整理蛋白质信息以阐明可药用基因组

2016-11-29189
OAAI
Open Targets: a platform for therapeutic target identification and validation
2016-11-29298
OAAI
The ChEMBL database in 2017

ChEMBL数据库2017年

2016-11-281.6K
OAAI